In-Vitro Diagnostics Market Growth, Size, Segmentation, Future Demands, Regional Forecast to 2025

UnivDatos Market Insights released a report titled “In-Vitro Diagnostics Market by Product (Reagents and Instruments Services), Techniques (Immunoassay, Clinical Chemistry, Self-Monitoring of Blood Glucose (SMBG), Molecular Diagnostics, Hematology, Microbiology, Point-of-Care, Hemostasis), Application (Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disease, Others), End-User (Hospitals, Clinics & Laboratory, Home Care, Other Healthcare Facility), Usability (Disposable and Reusable) and Region (North America, Europe, Asia-Pacific and Rest of World) - Current Analysis and Forecast (2019-2025).” According to the analysis, the market was valued at US$ 68.92 billion in 2018 and is predicted to reach US$ 98.18 billion by 2025. The market registered a CAGR of 5.24%  during the forecast period (2019-2025).

Request for full report- https://univdatos.com/get-a-free-sample-form-php/?product_id=5217
 
Market Dynamics

The report put forward both quantitative and qualitative industry analysis. Qualitative factors include several drivers and opportunities. It was estimated by WHO that, the proportion of the burden of Noncommunicable diseases (NCDs) will reach 57% by 2020. They possess one of the biggest health challenges throughout the globe. It has also been estimated that by 2030, the global population aged 60 years or over will occupy more than 56%. The rising geriatric population also leads to an increase in age-related disorders thereby influencing the market growth. The popularity of Point of Care devices will further influence the market growth as these compact devices lead to the diagnosis within less time frame. The report also provides a trend analysis of the market. Changing reimbursement models and regulations, investing in unifying technology, consolidation, and automation of labs, and shift to data-driven healthcare are some of the major trends. However, stringent government regulations for the manufacturing of IVD products and unfavorable reimbursement policies for in-vitro diagnostics will restrain market growth.

The report also highlights the regulations and reimbursement policy in several countries such as the US, China, India, Japan, Australia, and Europe. Cost and benefits of diagnostic testing have also been provided to offer the stakeholders with the overall scenario as most treatment decisions today are based on IVD results.

By Product, the market is primarily bifurcated into

• Reagents
• Instruments Services

Reagents are essential components of IVD kits. They consist of surfactants, buffers, dyes, and basic chemicals. These reagents are used for setting up a reaction to the diagnosis of the disease. Special chemistry testing laboratories and clinical chemistry laboratories use them for an accurate diagnosis. Reagents dominated the product segment of the global In-Vitro Diagnostics market with a 69% share in 2018.

By Technique, the market is primarily bifurcated into

• Immunoassay
• Clinical Chemistry
• Self-Monitoring of Blood Glucose (SMBG)
• Molecular Diagnostics
• Hematology
• Microbiology
• Point-of-Care
• Hemostasis

Among techniques, Immunoassay occupied the largest share of 24.7% in 2018 and is expected to maintain its dominance throughout the forecast period 2019-2025. Immunoassay is deployed for the diagnosis of several infectious diseases. The popularity of SMBG is also increasing for keeping a regular check on the blood glucose level, as the diabetic population is increasing globally.
 
By Application, the market is primarily bifurcated into

• Infectious Disease
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Disease
• Others

In 2018, IVD was majorly used for the treatment and diagnosis of Infectious Diseases. The segment is anticipated to witness growth with a CAGR of 4.89% during the forecast period 2019-2025. Moreover, the escalating prevalence of these diseases will increase the application of IVD for their detection. For instance, it has been estimated that 9.3% (463 million people) globally were suffering from diabetes. This figure is estimated to reach 10.9% (700 million) by 2045.

By End-User, the market is primarily bifurcated into

• Hospitals
• Clinics & Laboratory
• Home Care
• Others

IVD is used in hospitals, clinics & laboratories, home care, and other healthcare facilities The hospital is the major end-user of IVD and registered the maximum market growth. Point of care tests are compact such as pregnancy strips, fertility tests, and can be used in home settings. The results are provided by these tests much earlier as compared to the traditional tests.
 

Download Free Sample of this  Report- https://univdatos.com/get-a-free-sample-form-php/?product_id=5217
 
By Usability, the market is primarily bifurcated into

• Disposable IVD Devices
• Reusable IVD Devices

The Reusable IVD Devices occupied the largest share and is projected to maintain its dominance throughout the forecast. These IVD devices can be used again after thorough cleaning and disinfection.

Global In-Vitro Diagnostics Market Geographical Segmentation Includes:

• North America (United States, Canada and Rest of NA)
• Europe (Germany, United Kingdom, France, Italy, Spain and Rest of Europe)
• Asia-Pacific (China, Japan, India, Australia and Rest of APAC)
• Rest of World (Brazil and Other Rest of World)

Based on the estimation, North America dominated the In-Vitro Diagnostics market. Rising incidence of chronic diseases, escalating geriatric population, and high healthcare spending are major factors attributed to this dominance. Moreover, the presence of several players in the region also provides the country with a first-mover advantage.

 

The major players targeting the market includes

• Abbott Laboratories
• Becton Dickinson
• Biomérieux SA
• Bio-Rad Laboratories, Inc
• Danaher Corporation
• Johnson & Johnson
• Roche Holding AG
• Siemens Healthineers AG
• Thermo Fisher Scientific
• Sysmex Corporation

The competitive landscape has been provided pointing out the position of the key market players in the market along with the market share that is held by major players. These players are constantly working on expanding the market reach through M&A’s along with partnerships.

Table Of Content:
 

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY

3 COMPREHENSIVE ASSESSMENT OF THE VALUE OF DIAGNOSTIC TESTS

4 REFRAMING THE DIAGNOSTICS INDUSTRY

5 COSTS AND BENEFITS OF DIAGNOSTIC TESTING

6 RISK MITIGATION

7 CURRENT AND FUTURE USE OF DIAGNOSTIC PRODUCTS

8 EXECUTIVE SUMMARY

9 INDUSTRY PERFORMANCE

10 MARKET OVERVIEW

11 REGULATIONS AND REIMBURSEMENT POLICY

12 KEY MARKET INDICATORS

13 ROLE OF IN-VITRO DIAGNOSTICS IN HEALTHCARE

14 MARKET INSIGHT BY PRODUCT

15 MARKET INSIGHT BY TECHNIQUES

16 MARKET INSIGHT BY APPLICATION

17 MARKET INSIGHT BY END-USER

18 MARKET INSIGHT BY USABILITY

19 MARKET INSIGHT BY REGION

20 COMPETITIVE SCENARIO

21 TOP COMPANY PROFILES

About UnivDatos Market Insights
UnivDatos Market Insights (UMI) is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in delivering insights through Market Intelligence Reports, Customized Business Research, and Primary Research. Our research studies are spread across topics across the world, we cover markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, detailed analysis, and customized reports that help shape winning business strategies for our clients.

Contact
UnivDatos Market Insights
Pawnendra Pawan
Client Development Lead
Ph: +91-7838604911
Email: [email protected]
Website: https://univdatos.com/